Janssen Overview

  • Founded
  • 1953
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 100,000
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 10

Janssen General Information

Description

Manufacturer and developer of pharmaceutical products. The company's activities include research, development, manufacturing and marketing of pharmaceutical products for wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer, enabling customers to improve their health condition.

Contact Information

Website
Formerly Known As
N.V. Laboratoria Pharmaceutica, Laboratoria Pharmaceutica
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 1000 U.S. Route 202 South
  • Raritan, NJ 08869
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen‘s full profile, request access.

Request a free trial

Janssen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer and developer of pharmaceutical products. The company's activities include research, development, manufactu
Pharmaceuticals
Raritan, NJ
100,000 As of 2019
000000&0

000000 0

m dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
000000000000000
Rutherford, NJ
000 As of 0000
000.00
000000000 000.00

00000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
000000000000000
Aachen, Germany
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Janssen Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cancer Genetics Formerly VC-backed Rutherford, NJ 000 000.00 000000000 000.00
0000000000 Private Debt Financed Aachen, Germany 0000 00000 000000000 00000
00000000 000000000 Formerly VC-backed Marlborough, MA 0000 000000&0
00000000 000000000 Corporation Gaithersburg, MD 0000 000.00 000000000 000.00
00000000 Corporation Valby, Denmark 0000 00000000
You’re viewing 5 of 28 competitors. Get the full list »

Janssen Executive Team (2)

Name Title Board Seat Contact Info
Patrick Verheyen Head, Business Development
To view Janssen’s complete executive team members history, request access »

Janssen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Janssen Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 30-Dec-2019 000000000 00000 00 00000 Buildings and Property
000000000 01-Jan-2018 000000000 Biotechnology
0000000 0000000 01-Nov-2017 00000 Decision/Risk Analysis
00000000 000000000 06-Jun-2016 00000 00000 Biotechnology
HelixNano 09-Dec-2014 Accelerator/Incubator Biotechnology
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Janssen Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 01-Jul-2014 000 000.00 Completed
  • 4 buyers
00000000000 17-Aug-2009 0000 000.00 Completed
  • 2 buyers
Minerva Neurosciences Early Stage VC Completed
  • 4 buyers
To view Janssen’s complete exits history, request access »